These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 10649166)

  • 1. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group.
    Branch DW; Peaceman AM; Druzin M; Silver RK; El-Sayed Y; Silver RM; Esplin MS; Spinnato J; Harger J
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):122-7. PubMed ID: 10649166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.
    Pattison NS; Chamley LW; Birdsall M; Zanderigo AM; Liddell HS; McDougall J
    Am J Obstet Gynecol; 2000 Oct; 183(4):1008-12. PubMed ID: 11035355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
    Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L
    Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
    Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
    Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy complicated by the antiphospholipid syndrome: outcomes with intravenous immunoglobulin therapy.
    Clark AL; Branch DW; Silver RM; Harris EN; Pierangeli S; Spinnato JA
    Obstet Gynecol; 1999 Mar; 93(3):437-41. PubMed ID: 10074995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?
    Chaemsaithong P; Cuenca-Gomez D; Plana MN; Gil MM; Poon LC
    Am J Obstet Gynecol; 2020 May; 222(5):437-450. PubMed ID: 31494125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
    Dendrinos S; Sakkas E; Makrakis E
    Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of fetal death in the antiphospholipid antibody syndrome.
    Cowchock S
    Lupus; 1996 Oct; 5(5):467-72. PubMed ID: 8902784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.
    Farquharson RG; Quenby S; Greaves M
    Obstet Gynecol; 2002 Sep; 100(3):408-13. PubMed ID: 12220757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
    Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G
    Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women.
    Le Thi Thuong D; Tieulié N; Costedoat N; Andreu MR; Wechsler B; Vauthier-Brouzes D; Aumaître O; Piette JC
    Ann Rheum Dis; 2005 Feb; 64(2):273-8. PubMed ID: 15647435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
    Rai R; Cohen H; Dave M; Regan L
    BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The obstetric outcome following treatment in a cohort of patients with antiphospholipid antibody syndrome in a tertiary care center.
    Dadhwal V; Sharma AK; Deka D; Gupta B; Mittal S
    J Postgrad Med; 2011; 57(1):16-9. PubMed ID: 21206127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy.
    Spinnato JA; Clark AL; Pierangeli SS; Harris EN
    Am J Obstet Gynecol; 1995 Feb; 172(2 Pt 1):690-4. PubMed ID: 7856708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
    Hoffman MK; Goudar SS; Kodkany BS; Metgud M; Somannavar M; Okitawutshu J; Lokangaka A; Tshefu A; Bose CL; Mwapule A; Mwenechanya M; Chomba E; Carlo WA; Chicuy J; Figueroa L; Garces A; Krebs NF; Jessani S; Zehra F; Saleem S; Goldenberg RL; Kurhe K; Das P; Patel A; Hibberd PL; Achieng E; Nyongesa P; Esamai F; Liechty EA; Goco N; Hemingway-Foday J; Moore J; Nolen TL; McClure EM; Koso-Thomas M; Miodovnik M; Silver R; Derman RJ;
    Lancet; 2020 Jan; 395(10220):285-293. PubMed ID: 31982074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IRELAnD study-investigating the role of early low-dose aspirin in diabetes mellitus: a double-blinded, placebo-controlled, randomized trial.
    Finnegan C; Dicker P; Asandei D; Higgins M; O'Gorman N; O' Riordan M; Dunne F; Gaffney G; Newman C; McAuliffe F; Ciprike V; Fernandez E; Malone FD; Breathnach FM
    Am J Obstet Gynecol MFM; 2024 Apr; 6(4):101297. PubMed ID: 38461094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pregnancy outcome in 54 patients with antiphospholipid syndrome: a retrospective clinical study].
    Zheng XJ; Deng XL; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 46(2):323-8. PubMed ID: 24743831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction.
    McLaughlin K; Hobson SR; Chandran AR; Agrawal S; Windrim RC; Parks WT; Bowman AW; Sovio U; Smith GC; Kingdom JC
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1145-S1156.e1. PubMed ID: 34461078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.